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Abstract
Posterior polymorphous corneal dystrophy (PPCD) is a rare autosomal dominant genetically heterogeneous disorder.
Nineteen Czech PPCD pedigrees with 113 affected family members were identified, and 17 of these kindreds were
genotyped for markers on chromosome 20p12.1- 20q12. Comparison of haplotypes in 81 affected members, 20 unaffected
first degree relatives and 13 spouses, as well as 55 unrelated controls, supported the hypothesis of a shared ancestor in 12
families originating from one geographic location. In 38 affected individuals from nine of these pedigrees, a common
haplotype was observed between D20S48 and D20S107 spanning approximately 23 Mb, demonstrating segregation of
disease with the PPCD1 locus. This haplotype was not detected in 110 ethnically matched control chromosomes. Within the
common founder haplotype, a core mini-haplotype was detected for D20S605, D20S182 and M189K2 in all 67 affected
members from families 1–12, however alleles representing the core mini-haplotype were also detected in population
matched controls. The most likely location of the responsible gene within the disease interval, and estimated mutational
age, were inferred by linkage disequilibrium mapping (DMLE+2.3). The appearance of a disease-causing mutation was dated
between 64–133 generations. The inferred ancestral locus carrying a PPCD1 disease-causing variant within the disease
interval spans 60 Kb on 20p11.23, which contains a single known protein coding gene, ZNF133. However, direct sequence
analysis of coding and untranslated exons did not reveal a potential pathogenic mutation. Microdeletion or duplication was
also excluded by comparative genomic hybridization using a dense chromosome 20 specific array. Geographical origin,
haplotype and statistical analysis suggest that in 14 unrelated families an as yet undiscovered mutation on 20p11.23 was
inherited from a common ancestor. Prevalence of PPCD in the Czech Republic appears to be the highest worldwide and our
data suggests that at least one other novel locus for PPCD also exists.
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Introduction
Posterior polymorphous corneal dystrophy (PPCD) is a rare
bilateral disorder transmitted as an autosomal dominant trait.
Clinically PPCD is characterized by vesicles, bands and poly-
morphous opacities with pathology at the level of Descemet
membrane and the corneal endothelium. Peripheral anterior iris
adhesions, iris atrophy, pupillary ectropion and corectopia may
also develop. Occasional severe visual disability results from
secondary glaucoma or corneal edema [1–3]. On ultrastructural
examination, corneal endothelial cells show fibroblastic and
epithelial-like transformation [4–7].
The genetic heterogeneity of PPCD is currently known to be
represented by three loci on chromosomes 20, 1, and 10 [8–11].
PPCD1 (MIM ID #122000) is located on 20p11.21. Mutation of
the visual system homeobox gene 1 (VSX1; MIM ID #605020)
within this locus was reported as disease-causing in a few PPCD
cases [12,13]. PPCD2 (MIM ID #609140) is caused by mutation
of the alpha-2 chain of type VIII collagen gene (COL8A2; MIM ID
#120252) located on 1p34.3-p32.3, however only one disease-
causing mutation in one family has been described to date [9].
Mutations in the zinc finger E-box binding homeobox 1 gene
(ZEB1; MIM ID #189909) mapping to chromosome 10p11.2
were identified as disease-causing in PPCD3 (MIM ID #609141)
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and it has been estimated that pathogenic changes within this gene
account for approximately 25% of all PPCD cases, with a range
from 9%–45% depending on population studied [14–16]. We
have previously shown that in two Czech families PPCD is linked
to the short arm of chromosome 20, flanked by the markers
D20S48 and D20S139 [11]. Exclusion of VSX1 from this genetic
interval by a linkage study, and lack of disease-causing changes,
implies that an as yet undiscovered gene is causative for PPCD1
[11].
Families affected by rare dominantly inherited disorders are
often unrelated, however occasionally they share a chromosomal
genomic region implying that the pathogenic mutation arose in
a common ancestor [17].
In this study we observed that PPCD in the Czech Republic
appears to have a remarkably high prevalence. A total of 19 Czech
PPCD families, including two previously linked pedigrees [11],
were ascertained and members of 17 pedigrees were genotyped for
microsatellite markers spanning a region from 20p12.1 to 20q12.
We correlated the observed haplotypes with geographical origin of
the eldest family member known to suffer from the disorder and
demonstrate that the high prevalence of PPCD in the Czech
Republic is due to a common founder.
Materials and Methods
Patients
The study was approved by the Ethics Committee of General
University Hospital in Prague, Czech Republic and conformed to
the tenets of the Declaration of Helsinki. All participants signed an
informed consent prior to inclusion into the study.
Subjects from 19 Czech pedigrees with familial PPCD were
examined between the years 1995–2010 in the Department of
Ophthalmology of the First Faculty of Medicine, Charles
University in Prague. Ophthalmologic assessment included visual
acuity, slit lamp examination, intraocular pressure measurements
and specular microscopy using Noncon ROBO Pachy SP-9000
(Konan Medical Inc, Tokyo). Diagnosis of PPCD was based on
positive family history and the presence of vesicles and poly-
morphic opacities at the level of Descemet membrane and the
corneal endothelium. Pedigrees were drawn and residency within
the Czech Republic of the eldest family member known to suffer
from PPCD was noted. Geographic origin of the families was
plotted on a map.
Genotyping and Haplotype Analysis
DNA was isolated from venous blood samples using the
Nucleon III BACC3 genomic DNA extraction kit according to
manufacturer’s instructions (GE Healthcare, UK). Genotyping
was performed using 11 polymorphic microsatellite markers on
chromosome 20 which were fluorescently labeled and amplified by
polymerase chain reaction (PCR). Ten microsatellites were
commercially available: D20S98, D20S118, D20S114, D20S48,
D20S605, D20S182, D20S139, D20S190, D20S106 and
D20S107 (Invitrogen, Paisley, UK). A dinucleotide marker used
in this study, M189K21, was reported previously [11]. Amplifi-
cation was performed in 25 ml reaction volumes. Markers were
run on an ABI 3100 and analyzed using Genescan and Genotyper
software (Applied Biosystems, Foster City, CA).
To investigate the possibility of a common lineage, haplotypes
of affected individuals were constructed based on segregation
within the families, and then compared between families. In order
to calculate allele frequencies and haplotype frequencies in the
population, 55 unrelated Czech population matched controls (110
chromosomes) were also genotyped for each marker.
Analysis of the Disease Gene Location and Age of the
Mutation
To infer the location of a gene responsible for PPCD1 in the
population studied and to estimate the age of the mutation (i.e.
the time elapsed since the appearance of the common ancestor
in the population) DMLE+ (Disease Mapping using Linkage
disequilibrium) version 2.3 (www.dmle.org) was used. The
program DMLE+ uses Bayesian estimates of the location of
a gene with a mutation affecting a discrete (disease) trait based
on the observed linkage disequilibrium at multiple genetic
markers. Other parameters are also estimated, such as mutation
age [18,19].
Input for this analysis was the common PPCD genotypes of
affected individuals originating from the same geographic
location, and the haplotypes of population matched control
individuals. Prior to DMLE+2.3 analysis, haplotypes of un-
related controls were predicted using the PHASE program
[20,21]. Genetic distances of individual markers used in the
analysis were taken from the Marshfield genetic map (http://
research.marshfieldclinic.org/genetics/GeneticResearch/
compMaps.asp). For markers which do not appear on this
genetic map (D20S98, D20S48, M189K21, D20S139) the
distance in cM was estimated empirically by interpolation using
the standard curve of physical distance. Since DMLE+2.3 does
not accept identical distances for more than one marker, where
the position of two markers obtained from the Marshfield
genetic map was identical (i.e. D20S118, D20S114, D20S605,
D20S182) position was recalculated using the standard curve as
above (see Supporting Information Table S1). The following
variable values were used in the DMLE+2.3 analysis: population
growth rate of 0.95. This was calculated from an estimated
population size of 100,000 inhabitants 2000 years ago and
current population size of 6,700,000 inhabitants living in the
historic regions of Bohemia that have been historically compact.
The estimated frequency of the disease in the population was
set at 0.001.
Screening the ZNF133 Gene
Two probands from families 1 and 2, previously shown to be
linked to 20p11.2 [11], as well as one unaffected first-degree
relative from family 2 were screened. Amplification was carried
out in a 25 ml reaction containing 12.5 ml of ReddyMixTM PCR
master mix (ABgene Limited, Epsom, UK), with 50 pmoles gene-
specific primers (see Supporting Information Table S2) and
approximately 50 ng of genomic DNA. The PCR amplicons were
purified and sequenced on both strands as previously described
[22]. Nucleotide sequences were compared with the published zinc
finger protein 133 (ZNF133; MIM ID #604075) reference
sequence (NM_003434 and NM_001083330). Both coding and
untranslated regions as well as intron-exon boundaries were
screened.
Comparative Genomic Hybridisation
Array comparative genomic analysis (CGH) was used to
evaluate DNA copy number variation (CNV) on chromosome
20 (NimbleGen, Berlin, Germany) with a median probe spacing of
134 bp. Patient DNA from family 1, previously shown to be linked
to 20p11.2 [11], was labeled with Cy-3 and a reference sex
matched DNA sample was labeled with Cy5. Array construction,
labeling, hybridisation, and normalisation were performed by
NimbleGen. The data were visualised and analysed using
SignalMap software (NimbleGen).
Founder Effect for Czech PPCD1
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Results
Clinical ascertainment demonstrated bilateral corneal changes
consistent with the diagnosis of PPCD in 113 subjects (48 males,
65 females) from 19 families. None of the PPCD families were
known to be related to one another. In all families PPCD was
consistent with autosomal dominant inheritance pattern, with
incomplete penetrance noted for family 18 and 19 [23]. Of these,
32 patients were from two large pedigrees (families 1 and 2)
previously linked to the short arm of chromosome 20 [11].
Families 1–14 originated from the western or southwestern part of
the Czech Republic, 12 of which were from a small region of
approximately 13 km radius around the town of Klatovy (Figure 1)
with an estimated current population of 30,000 inhabitants. Out of
the 19 families identified, 81 affected individuals from 17 families
were genotyped, including members of the two families in which
linkage analysis was previously performed [11]. Table 1 sum-
marizes the number of individuals genotyped for each family, their
clinical status, molecular genetic findings and geographical origin
within the Czech Republic.
Analysis of genetic markers on 20p12.1- 20q12 revealed
a common haplotype spanning a region of at least 23 Mb
surrounding the centromere and encompassing both the short and
long arm of chromosome 20. This full common haplotype was
detected in 16 affected members of the two previously linked
PPCD1 families (1 and 2) and also in 22 affected members from
families 3–8 and 12 (see Supporting Information Table S3). None
of the 55 population matched controls had a combination of
markers that would allow for reconstruction of this full haplotype.
The founder haplotype segregated with disease in families with
more than one genotyped affected individual. In all 67 affected
members from families 1–12 a core shared mini-haplotype was
detected for D20S605, D20S182 and M189K2. The boundary of
this haplotype was defined by recombinations with flanking
markers D20S48 and D20S139 as less than 2.4 Mb (see
Supporting Information Table S3). However, alleles representing
this mini-haplotype were also found in 12 controls out of 55.
In families 15–19, analysis did not reveal the common shared
haplotype detected in families clustered from the southwest part of
the Czech Republic. In family 15, segregation of genotyped
markers on 20p12.1-20q12 with PPCD was not observed
suggesting they are not linked to this locus. In family 16, only
two affected family members were genotyped and in families 17
and 19 only the proband was available for genotyping, thus
assessment of haplotype segregation with disease could not be
reliably performed (see Supporting Information Table S3).
Analysis of the haplotypes using DMLE+2.3 yielded an estimate
that families 1–12 had a common ancestor originating between
64–133 generations ago, with maximum posterior probability at
90 generations; i.e. 1800 years assuming a 20-year generation time
or 2250 years with a 25-year generation time (Figure 2). The
mutation locator identified the potential locus harboring the
ancestral disease-causing change between D20S182 and
M189K21 (Figure 3) with 95% confidence. This interval
corresponds to a physical distance of only 60 Kb which contains
one known protein coding gene; ZNF133.
The ZNF133 gene was therefore screened by direct sequencing
for a mutation in probands from two Czech PPCD1 families
Figure 1. Geographical origin of families with posterior polymorphous corneal dystrophy within the southwestern part of the
Czech Republic. The geographical origin of the eldest members of each family is indicated by *. Twelve of the families, of which ten were
genotyped and shown to share common haplotype, can be traced to a region of 13 km radius around the town of Klatovy. Two other genotyped
families with the common full haplotype spanning over 23 Mb originate from an approximate 40 km radius from Klatovy, however knowledge of the
place of origin only extended to three generations in both families.
doi:10.1371/journal.pone.0045495.g001
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Figure 2. Estimated age for posterior polymorphous corneal dystrophy linked to 20p12.1-20p11.23 in Czech patients. Maximum
probability represented by 5% significance interval shown as filled triangles was found at 90 generations (range 64 to 133), i.e. 1800 years assuming
a 20-year generation time.
doi:10.1371/journal.pone.0045495.g002
Figure 3. Predicted location of the putative mutation causing posterior polymorphous corneal dystrophy on 20p11.23. Filled
triangles show 5% significance level of disease mutation location on chromosome 20 in cM; a 60 kb region between markers D20S182 and M189K21.
doi:10.1371/journal.pone.0045495.g003
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(1 and 2), however no potential pathogenic changes in the
annotated coding and untranslated regions were identified. Since
a deletion or duplication of the ZNF133 gene would not be
detected by PCR amplification and sequencing, we also performed
dense chromosome 20 CGH analysis (Nimblegen) to detect any
CNVs in an affected individual from family 1. No microdeletions
or duplications on 20p12.1-20p11.23 were detected in this patient.
Discussion
Identification of 113 affected individuals from 19 Czech PPCD
families demonstrates, to the best of our knowledge, the highest
reported prevalence of PPCD worldwide. Correlated to the
population, at least 1 in 100,000 inhabitants in the Czech
Republic are affected with PPCD. Because of the relative rarity of
this disorder, a founder effect was suspected as the most likely
explanation.
In this study we show that 38 affected individuals from nine
families, including two previously reported families [11], who
originate from a particular region within the Czech Republic
display a common disease-associated haplotype across a region of
at least 23 Mb on chromosome 20. This particular combination of
marker alleles was not detected in any of the 55 ethnically matched
controls (110 chromosomes) and is therefore markedly over-
represented in Czech PPCD families. In addition, 29 affected
individuals from 12 families display only part of the disease-
associated haplotype, however corroboration of regional clustering
also supports the hypothesis that they are descendants of the same
ancestor. In two families (13 and 14) affected individuals were not
available for genotyping, however because of their geographical
origin from the same region as pedigrees 1–12 and the severity of
their phenotype, it is likely that they would also share the same
common ancestor. Since the information on family origin was
based on the eldest member known to clearly suffer from PPCD,
we could only trace ancestors back to the last century. Despite the
fact that some families originated in nearby villages we were not
able to link the pedigrees so they were considered as unrelated for
the statistical analyses.
Affected individuals within Czech PPCD1 pedigrees were
observed in all subsequent generations implying that the disorder
is highly if not fully penetrant, consistent with other studies [8,24].
Although the fully shared haplotype among members of nine
families comprised about 1/3 of chromosome 20 including the
centromere and pericentromeric regions, we have calculated that
the original mutational event did not occur recently. Since the
families originate from one particular geographical area, we
assume that they represent a relatively isolated population, which
are known to have more extensive linkage disequilibrium than
outbred populations [25]. In addition, some regions of genomes
are less prone to recombination and large regions of linkage
disequilibrium have been shown to occur especially around the
centromere [26,27].
The mutation age was estimated to be 1800 years assuming a 20-
year generation time. It remains to be elucidated if the disease-
causing variant arose in the Czech Republic and is specific for that
particular geographical region or if it is an ancient mutation
introduced from elsewhere. Once the PPCD1 causing gene is
discovered it will be possible to further explore these hypotheses.
The minimal shared region in families 1–12 was observed
between D20S48 and D20S139, which corresponds to the locus
delineation by linkage analysis we described previously in Czech
families [11]. Yellore et al. narrowed the proximal boundary of the
PPCD1 genetic interval to D20S182 defining the critical disease
physical interval to a 1.8 Mb region, under the assumption that
there is no micro-heterogeneity [24]. Despite the fact that the
PPCD1 locus has been refined to a relatively small interval, the
disease-causing gene still remains to be identified even after next-
generation sequence analysis of the entire selectively enriched
chromosomal region between markers D20S48 and D20S190
[28].
The strongest candidate disease gene based on our current
analysis is ZNF133 which is a transcriptional repressor containing
KRAB box and zinc finger domains [29] with corneal endothelial
expression (http://www.corneanet.net/) [30]. Coupled with the
fact that mutations in another zinc finger protein are already
known to cause PPCD3 [14] we considered ZNF133 to be the best
positional candidate in the refined PPCD1 region, however we did
not detect a pathogenic change within currently annotated coding
or untranslated regions of this gene. Similarly, no pathogenic
variants were observed for ZNF133 in two other studies using
probands from different PPCD families linked to chromosome 20
[28,31]. A CNV or balanced translocation was also considered,
however routine karyotype examination in probands from families
1 and 2, and CGH analysis of an affected member of family 1 did
not identify any gross or subtle CNVs at this locus. The lack of
identification of a pathogenic mutation suggests that if ZNF133 is
disease-causing, the change might be located in regulatory
sequences, as yet unidentified exons or deep within the introns
of this gene.
The data presented here, taken together with previous linkage
studies, candidate gene screening, targeted genomic next-genera-
tion sequencing [8,11,25,28,31] and our CGH data excluding
a CNV, it is perhaps surprising that the causative mutation/gene
has not been identified. Potential for locus micro-heterogeneity
may be hindering progress. In addition our current functional
knowledge of candidate genes in the interval, including ZNF133, is
very limited such that splice variants and important elements
controlling transcription remain undefined. The causative muta-
tions may lie in these uncharacterised upstream regions, exons,
and introns or within as yet undiscovered genes on 20p12.1-
20p11.23. Independent analysis of each family, by targeted next
generation sequencing of the disease interval defined by
recombinations within a single large linked family, would
circumvent any assumption of locus homogeneity, and may
represent the most comprehensive approach, if complemented
with Sanger sequencing of gaps and gene expression studies.
Families 15–19 apparently originate from different parts of the
country than families 1–14 and these families provided an
excellent internal control for our analyses. None of these kindreds
had the full consensus haplotype and, with the exception of the
proband from family 19, they did not share the minimal core
haplotype segment found in all 64 affected individuals from
pedigrees 1–12. Based on these observations, it is likely that PPCD
in these families is caused by a different mutation or a different
gene. In support of this, disease-causing mutations in ZEB1 were
detected in families 18 and 19 [23]. No mutations in coding
regions of any currently known PPCD genes were detected in
families 15–17 which suggests that a novel PPCD locus may exist
[23] (Table 1).
We conclude that in the Czech population ZEB1 changes
account for approximately 4% cases, whereas a disease-causing
gene at the 20p12.1-20p11.23 locus is likely to be responsible for
more than 80% of all PPCD cases. A recent study by Vincent et al.
highlights the fact that in some cohorts ZEB1 accounts for a smaller
proportion of cases than originally thought [14–16].
Clinical implications of our study lie in the fact that PPCD1
seems to be more severe showing a higher percentage of secondary
glaucoma and necessity for keratoplasty than PPCD3, which has
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a direct impact on patient counseling [32]. Our data suggests that
once the PPCD1 gene is identified, it will account for the majority
of PPCD in the Czech Republic thus a diagnostic test could be
readily developed which would benefit this patient group.
In summary we have demonstrated that the high frequency of
PPCD in the Czech Republic is attributable to a founder mutation
located on 20p12.1-20p11.23. The disease gene and causative
variant have yet to be identified. We anticipate that approximately
80% of PPCD in the Czech population will be attributed to the
mutant allele at the locus on chromosome 20p, however it is also
clear that other PPCD genes or alleles are implicated as not all
families described in this study share a common founder
haplotype. Consistent with this finding ZEB1 mutations were
previously identified in two families (18, 19), and lack of the
PPCD1 haplotype in two families (16, 17) suggests they may not be
associated with the PPCD1 locus. In family 15, the PPCD1 locus is
excluded and no mutation was detected in VSX1, COL8A2 or
ZEB1 suggesting a novel locus may exist.
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